vs
STANDARD BIOTOOLS INC.（LAB）与西木工作室（WHG）财务数据对比。点击上方公司名可切换其他公司
西木工作室的季度营收约是STANDARD BIOTOOLS INC.的1.3倍（$25.0M vs $19.6M），西木工作室净利率更高（3.1% vs -177.4%，领先180.5%），西木工作室同比增速更快（7.4% vs -11.5%），过去两年西木工作室的营收复合增速更高（4.9% vs -12.2%）
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
西木工作室是总部位于美国内华达州拉斯维加斯的电子游戏开发商，1985年由布雷特·斯佩里与路易斯·卡斯特创立，最初名为Brelous Software，成立两个月后更名为西木合伙人，1992年维珍游戏收购后更名为西木工作室。1998年该工作室连同维珍互动北美业务一同被艺电收购。
LAB vs WHG — 直观对比
营收规模更大
WHG
是对方的1.3倍
$19.6M
营收增速更快
WHG
高出18.8%
-11.5%
净利率更高
WHG
高出180.5%
-177.4%
两年增速更快
WHG
近两年复合增速
-12.2%
损益表 — Q3 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $19.6M | $25.0M |
| 净利润 | $-34.7M | $782.0K |
| 毛利率 | 48.5% | — |
| 营业利润率 | -168.5% | — |
| 净利率 | -177.4% | 3.1% |
| 营收同比 | -11.5% | 7.4% |
| 净利润同比 | -28.8% | — |
| 每股收益（稀释后） | $-0.09 | $0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LABWHG
| Q1 26 | — | $25.0M | ||
| Q4 25 | — | $27.1M | ||
| Q3 25 | $19.6M | $24.3M | ||
| Q2 25 | $21.8M | $23.1M | ||
| Q1 25 | $40.8M | $23.3M | ||
| Q4 24 | — | $46.5M | ||
| Q3 24 | $22.1M | $23.7M | ||
| Q2 24 | $22.5M | $22.7M |
净利润LABWHG
| Q1 26 | — | $782.0K | ||
| Q4 25 | — | $1.8M | ||
| Q3 25 | $-34.7M | $3.7M | ||
| Q2 25 | $-33.5M | $1.0M | ||
| Q1 25 | $-26.0M | $478.0K | ||
| Q4 24 | — | $3.7M | ||
| Q3 24 | $-26.9M | $-1.2M | ||
| Q2 24 | $-45.7M | $-378.0K |
毛利率LABWHG
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 48.5% | — | ||
| Q2 25 | 48.8% | — | ||
| Q1 25 | 48.4% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 54.9% | — | ||
| Q2 24 | 46.1% | — |
营业利润率LABWHG
| Q1 26 | — | — | ||
| Q4 25 | — | 8.0% | ||
| Q3 25 | -168.5% | 8.3% | ||
| Q2 25 | -118.1% | 3.8% | ||
| Q1 25 | -80.8% | -0.3% | ||
| Q4 24 | — | 10.0% | ||
| Q3 24 | -120.9% | -2.1% | ||
| Q2 24 | -134.5% | -18.4% |
净利率LABWHG
| Q1 26 | — | 3.1% | ||
| Q4 25 | — | 6.8% | ||
| Q3 25 | -177.4% | 15.4% | ||
| Q2 25 | -153.7% | 4.5% | ||
| Q1 25 | -63.8% | 2.1% | ||
| Q4 24 | — | 14.5% | ||
| Q3 24 | -122.0% | -5.0% | ||
| Q2 24 | -203.3% | -1.7% |
每股收益（稀释后）LABWHG
| Q1 26 | — | $0.09 | ||
| Q4 25 | — | $0.21 | ||
| Q3 25 | $-0.09 | $0.41 | ||
| Q2 25 | $-0.09 | $0.12 | ||
| Q1 25 | $-0.07 | $0.05 | ||
| Q4 24 | — | $0.45 | ||
| Q3 24 | $-0.07 | $-0.15 | ||
| Q2 24 | $-0.12 | $-0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $129.4M | $23.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $399.7M | $126.1M |
| 总资产 | $539.6M | $150.4M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资LABWHG
| Q1 26 | — | $23.4M | ||
| Q4 25 | — | $47.7M | ||
| Q3 25 | $129.4M | $41.3M | ||
| Q2 25 | $158.6M | $35.2M | ||
| Q1 25 | $150.9M | $29.1M | ||
| Q4 24 | — | $46.5M | ||
| Q3 24 | $210.6M | $48.3M | ||
| Q2 24 | $269.8M | $44.1M |
总债务LABWHG
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $55.2M | — | ||
| Q2 24 | $55.1M | — |
股东权益LABWHG
| Q1 26 | — | $126.1M | ||
| Q4 25 | — | $125.6M | ||
| Q3 25 | $399.7M | $123.9M | ||
| Q2 25 | $424.5M | $122.4M | ||
| Q1 25 | $454.6M | $121.4M | ||
| Q4 24 | — | $120.3M | ||
| Q3 24 | $489.3M | $120.4M | ||
| Q2 24 | $510.3M | $120.5M |
总资产LABWHG
| Q1 26 | — | $150.4M | ||
| Q4 25 | — | $162.3M | ||
| Q3 25 | $539.6M | $154.0M | ||
| Q2 25 | $557.0M | $146.3M | ||
| Q1 25 | $579.6M | $135.0M | ||
| Q4 24 | — | $150.0M | ||
| Q3 24 | $681.5M | $151.5M | ||
| Q2 24 | $708.7M | $147.4M |
负债/权益比LABWHG
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.11× | — | ||
| Q2 24 | 0.11× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.2M | $-2.6M |
| 自由现金流经营现金流 - 资本支出 | $-23.1M | — |
| 自由现金流率自由现金流/营收 | -118.1% | — |
| 资本支出强度资本支出/营收 | 4.5% | — |
| 现金转化率经营现金流/净利润 | — | -3.28× |
| 过去12个月自由现金流最近4个季度 | $-111.1M | — |
8季度趋势，按日历期对齐
经营现金流LABWHG
| Q1 26 | — | $-2.6M | ||
| Q4 25 | — | $18.9M | ||
| Q3 25 | $-22.2M | $8.5M | ||
| Q2 25 | $-20.7M | $7.3M | ||
| Q1 25 | $-30.3M | $-4.9M | ||
| Q4 24 | — | $21.1M | ||
| Q3 24 | $-27.9M | $529.0K | ||
| Q2 24 | $-39.0M | $3.6M |
自由现金流LABWHG
| Q1 26 | — | — | ||
| Q4 25 | — | $18.8M | ||
| Q3 25 | $-23.1M | $8.5M | ||
| Q2 25 | $-22.6M | — | ||
| Q1 25 | $-35.3M | $-4.9M | ||
| Q4 24 | — | $21.0M | ||
| Q3 24 | $-30.1M | $519.0K | ||
| Q2 24 | $-41.0M | $3.5M |
自由现金流率LABWHG
| Q1 26 | — | — | ||
| Q4 25 | — | 69.5% | ||
| Q3 25 | -118.1% | 34.8% | ||
| Q2 25 | -103.6% | — | ||
| Q1 25 | -86.6% | -21.1% | ||
| Q4 24 | — | 45.2% | ||
| Q3 24 | -136.4% | 2.2% | ||
| Q2 24 | -182.2% | 15.6% |
资本支出强度LABWHG
| Q1 26 | — | — | ||
| Q4 25 | — | 0.3% | ||
| Q3 25 | 4.5% | 0.3% | ||
| Q2 25 | 8.7% | 0.0% | ||
| Q1 25 | 12.4% | 0.0% | ||
| Q4 24 | — | 0.2% | ||
| Q3 24 | 10.2% | 0.0% | ||
| Q2 24 | 8.6% | 0.1% |
现金转化率LABWHG
| Q1 26 | — | -3.28× | ||
| Q4 25 | — | 10.29× | ||
| Q3 25 | — | 2.29× | ||
| Q2 25 | — | 7.08× | ||
| Q1 25 | — | -10.25× | ||
| Q4 24 | — | 5.69× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
WHG
| Asset-based | $19.3M | 77% |
| Trust fees | $5.3M | 21% |
